DVA DaVita Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
20:20
Aug 14
Aug 14
Berkshire Hathaway's Q2 portfolio update reveals new positions in D.R.
Berkshire Hathaway's Q2 portfolio update reveals new positions in D.R. Horton and exits Constellation Brands, with major buys in Alphabet and Delta and significant cuts in Bank of America and Kroger.
13:58
Aug 06
Aug 06
Article reports DaVita shares fell about 17% after the kidney trial because slowing kidney decline shrinks the dialysis population, a direct structural negative for dialysis demand.
Article reports DaVita shares fell about 17% after the kidney trial because slowing kidney decline shrinks the dialysis population, a direct structural negative for dialysis demand.
Risk: Adoption of GLP-1s for kidney disease could be slower than projected, and DaVita has ancillary services that may offset some pressure.
21:00
Aug 04
Aug 04
Management reaffirmed full-year guidance, balancing volume growth tailwinds against RPT headwinds from commercial mix dilution and phosphate binder transition. The tone is cautiously optimistic but maintains existing targets.
HIGH
21:00
May 05
May 05
Management raised full-year guidance on stronger volume and cost performance, showing positive momentum.
HIGH
22:00
Feb 02
Feb 02
Management is confident in delivering 3.2% AOI growth and 33% EPS growth in 2026, driven by cost management, IKC profitability, and capital allocation, despite volume headwinds.
HIGH
About DVA Analyst Coverage
Buzzberg tracks DVA (DaVita) across 3 sources. 0 bullish vs 0 bearish calls from 3 analysts. Sentiment: evenly split. 5 total trade ideas tracked. Latest voices: unusual_whales, Chamath Palihapitiya, Javier Rodriguez.